Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Kathy Howell

Development of a Robust Flow Cytometry-Based Pharmacodynamic Assay to Detect Phospho-Protein Signals for Phosphatidylinositol 3-Kinase Inhibitors in Multiple Myeloma

Journal of Translational Medicine

English

A Soluble BAFF Antagonist, BR3-Fc, Decreases Peripheral Blood B Cells and Lymphoid Tissue Marginal Zone and Follicular B Cells in Cynomolgus Monkeys

American Journal of Pathology

Forensic Medicine

Pathology

2006

English

Related publications

Targeting the Phosphatidylinositol 3-Kinase Pathway in Multiple Myeloma

Clinical Cancer Research

Cancer Research

Oncology

2007

English

Clinical Development of Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin Lymphoma

Biomarker Research

Biochemistry

Molecular Medicine

Clinical Biochemistry

2013

English

Phosphatidylinositol 3-Kinase Inhibitors Are a Triple Threat to Ovarian Cancer

Clinical Cancer Research

Cancer Research

Oncology

2005

English

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors as Cancer Therapeutics

Journal of Hematology and Oncology

English

Phosphatidylinositol 3-Kinase Mediates Proliferative Signals in Intestinal Epithelial Cells

English

Development of a Pharmacodynamic Assay Based on PLCγ2 Phosphorylation for Quantifying Spleen Tyrosine Kinase (SYK)–Bruton’s Tyrosine Kinase (BTK) Signaling

Journal of Biomolecular Screening

English

Docking Study to Predict the Efficacy of Phosphatidylinositol 3-Kinase Α Inhibitors

ARO-THE SCIENTIFIC JOURNAL OF KOYA UNIVERSITY

2019

English

MAFb Protein Confers Intrinsic Resistance to Proteasome Inhibitors in Multiple Myeloma

English

Development of New Molecular Markers for Cancer: A Highly Sensitive Assay for Detecting Mutations of Phosphatidylinositol 3-Kinase and P53

Journal of Nippon Medical School

Medicine

2011

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Kathy Howell

Development of a Robust Flow Cytometry-Based Pharmacodynamic Assay to Detect Phospho-Protein Signals for Phosphatidylinositol 3-Kinase Inhibitors in Multiple Myeloma

A Soluble BAFF Antagonist, BR3-Fc, Decreases Peripheral Blood B Cells and Lymphoid Tissue Marginal Zone and Follicular B Cells in Cynomolgus Monkeys

Related publications

Targeting the Phosphatidylinositol 3-Kinase Pathway in Multiple Myeloma

Clinical Development of Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin Lymphoma

Phosphatidylinositol 3-Kinase Inhibitors Are a Triple Threat to Ovarian Cancer

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors as Cancer Therapeutics

Phosphatidylinositol 3-Kinase Mediates Proliferative Signals in Intestinal Epithelial Cells

Development of a Pharmacodynamic Assay Based on PLCγ2 Phosphorylation for Quantifying Spleen Tyrosine Kinase (SYK)–Bruton’s Tyrosine Kinase (BTK) Signaling

Docking Study to Predict the Efficacy of Phosphatidylinositol 3-Kinase Α Inhibitors

MAFb Protein Confers Intrinsic Resistance to Proteasome Inhibitors in Multiple Myeloma

Development of New Molecular Markers for Cancer: A Highly Sensitive Assay for Detecting Mutations of Phosphatidylinositol 3-Kinase and P53